NEW YORK (GenomeWeb News) – Illumina and Kindstar Global, a Chinese diagnostic testing service provider, have signed a strategic collaboration to introduce molecular assays based on Illumina products in Kindstar's laboratories, the companies said today.

The partnership involves Illumina's TruSight content sets for targeted next-generation sequencing, Infinium Dx CytoSNP-12 BeadChip assay, and NuPCR reagents for qPCR.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.